These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18031269)

  • 1. Enhancement of oligomeric stability by covalent linkage and its application to the human p53tet domain: thermodynamics and biological implications.
    Poon GM
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1574-8. PubMed ID: 18031269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tandem dimerization of the human p53 tetramerization domain stabilizes a primary dimer intermediate and dramatically enhances its oligomeric stability.
    Poon GM; Brokx RD; Sung M; Gariépy J
    J Mol Biol; 2007 Jan; 365(4):1217-31. PubMed ID: 17113101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meanfield approach to the thermodynamics of a protein-solvent system with application to the oligomerization of the tumor suppressor p53.
    Noolandi J; Davison TS; Volkel AR; Nie X; Kay C; Arrowsmith CH
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):9955-60. PubMed ID: 10944184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solvent-exposed residues located in the beta-sheet modulate the stability of the tetramerization domain of p53--a structural and combinatorial approach.
    Mora P; Carbajo RJ; Pineda-Lucena A; Sánchez del Pino MM; Pérez-Payá E
    Proteins; 2008 Jun; 71(4):1670-85. PubMed ID: 18076077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and functionality of a designed p53 dimer.
    Davison TS; Nie X; Ma W; Lin Y; Kay C; Benchimol S; Arrowsmith CH
    J Mol Biol; 2001 Mar; 307(2):605-17. PubMed ID: 11254385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nine hydrophobic side chains are key determinants of the thermodynamic stability and oligomerization status of tumour suppressor p53 tetramerization domain.
    Mateu MG; Fersht AR
    EMBO J; 1998 May; 17(10):2748-58. PubMed ID: 9582268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural stability of covalently linked GroES heptamer: advantages in the formation of oligomeric structure.
    Sakane I; Hongo K; Motojima F; Murayama S; Mizobata T; Kawata Y
    J Mol Biol; 2007 Apr; 367(4):1171-85. PubMed ID: 17303164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic computational alanine scanning: application to p53 oligomerization.
    Chong LT; Swope WC; Pitera JW; Pande VS
    J Mol Biol; 2006 Mar; 357(3):1039-49. PubMed ID: 16457841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folding and stability of a primitive protein.
    Riechmann L; Lavenir I; de Bono S; Winter G
    J Mol Biol; 2005 May; 348(5):1261-72. PubMed ID: 15854659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognate DNA stabilizes the tumor suppressor p53 and prevents misfolding and aggregation.
    Ishimaru D; Ano Bom AP; Lima LM; Quesado PA; Oyama MF; de Moura Gallo CV; Cordeiro Y; Silva JL
    Biochemistry; 2009 Jul; 48(26):6126-35. PubMed ID: 19505151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In the quest for stable rescuing mutants of p53: computational mutagenesis of flexible loop L1.
    Pan Y; Ma B; Venkataraghavan RB; Levine AJ; Nussinov R
    Biochemistry; 2005 Feb; 44(5):1423-32. PubMed ID: 15683227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of void volumes in proteins and application to stability of the p53 tumour suppressor protein.
    Cuff AL; Martin AC
    J Mol Biol; 2004 Dec; 344(5):1199-209. PubMed ID: 15561139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermodynamics of a designed protein catenane.
    Blankenship JW; Dawson PE
    J Mol Biol; 2003 Mar; 327(2):537-48. PubMed ID: 12628256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of Alzheimer's A beta peptide with an engineered binding protein--thermodynamics and kinetics of coupled folding-binding.
    Hoyer W; Härd T
    J Mol Biol; 2008 Apr; 378(2):398-411. PubMed ID: 18358490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered assembly of intertwined oligomers of an immunoglobulin chain.
    Hayes MV; Sessions RB; Brady RL; Clarke AR
    J Mol Biol; 1999 Jan; 285(4):1857-67. PubMed ID: 9917417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of metal ion on the structural stability of tumour suppressor protein p53 DNA-binding domain.
    Xue Y; Wang S; Feng X
    J Biochem; 2009 Aug; 146(2):193-200. PubMed ID: 19346293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering proteins with tunable thermodynamic and kinetic stabilities.
    Pey AL; Rodriguez-Larrea D; Bomke S; Dammers S; Godoy-Ruiz R; Garcia-Mira MM; Sanchez-Ruiz JM
    Proteins; 2008 Apr; 71(1):165-74. PubMed ID: 17932922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing the determinants of protein stability from covalent to non-covalent interactions by in vitro evolution: a structural and energetic analysis.
    Kather I; Jakob R; Dobbek H; Schmid FX
    J Mol Biol; 2008 Sep; 381(4):1040-54. PubMed ID: 18621056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A stable human p53 heterotetramer based on constructive charge interactions within the tetramerization domain.
    Brokx RD; Bolewska-Pedyczak E; Gariépy J
    J Biol Chem; 2003 Jan; 278(4):2327-32. PubMed ID: 12433927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.